COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome (ELPIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02398604
Recruitment Status : Terminated (Study was closed due to Sponsor switched to Longeveron. New Identifier is NTC03525418)
First Posted : March 25, 2015
Last Update Posted : June 25, 2019
University of Maryland, College Park
Information provided by (Responsible Party):
Joshua M Hare, University of Miami

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2019
Actual Study Completion Date : March 2019